Back

P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysis

30 August 2024 (12:00 - 12:10)
Organised by: Logo
Congress Presentation Part of: Antiplatelet therapy: novel approaches for acute coronary syndrome and percutaneous coronary intervention Antiplatelet Drugs ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Mattia Galli

Sapienza University of Rome, Rome (Italy)

5 More presentations in this session

Presentation thumbnail
Clopidogrel versus aspirin monotherapy for secondary prevention after percutaneous coronary intervention - a nationwide population-based study
Mr J. Cho (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Implementation of prasugrel and prognostic outcomes after percutaneous coronary intervention for myocardial infarction: a nationwide observational study
Doctor M. Jacobsen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Impact of different P2Y12 inhibitors in acute coronary syndrome patients with severe chronic kidney disease: insights from the CORALYS registry
Doctor F. Giacobbe (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Pretreatment with dual antiplatelet therapy in acute myocardial infarction
Professor Z. Motovska (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Cangrelor versus no cangrelor during percutaneous coronary intervention in hemodynamically unstable patients: a cohort study on benefits and risks
Mr O. Emilsson (Lund, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Antiplatelet therapy: novel approaches for acute coronary syndrome and percutaneous coronary intervention
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Ticagrelor monotherapy or DAPT after drug-eluting coronary stenting in patients with or without acute coronary syndrome: a patient-level meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
A shorter duration of dual-antiplatelet therapy following percutaneous coronary intervention: a meta-analysis of randomized clinical trials
thumbnail
Congress Presentation
Is aspirin the preferred monotherapy after DAPT?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources